Short-term aggressive disease management programs for heart failure: Effect on drug utilization, clinical outcomes, and costs

Disease Management and Health Outcomes

Volumn 12, Issue 4, 2004, Pages 221-227

  Akosah, Kwame O ^a,b,c   Carothers, Stephanie ^a  

^a GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c Gunderson Lutheran Health System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADD ON THERAPY; CLINICAL FEATURE; COMORBIDITY; CONGESTIVE HEART FAILURE; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DRUG COST; DRUG UTILIZATION; EARLY DIAGNOSIS; HEALTH CARE POLICY; HEALTH PROGRAM; HEART ATRIUM FIBRILLATION; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; KIDNEY FAILURE; LUNG DISEASE; MEDICAL SPECIALIST; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PATIENT EDUCATION; REVIEW; SURVIVAL RATE; TEAMWORK; TELECOMMUNICATION;

EID: 3943081297     PISSN: 11738790     EISSN: None     Source Type: Journal    
DOI: 10.2165/00115677-200412040-00002     Document Type: Review

References (31)

1. American Heart Association. 2003 heart and stroke statistical update [online]. Available from URL: http://www.americanheart.org/statistics/coronary. html [Accessed 2003 Mar 5]
2. Akosah KO, Moncher K, Schaper A, et al. Chronic heart failure in the community: missed diagnosis and missed opportunities. J Card Fail 2001; 7: 232-8
3. Davies MK, Hobbs FD, Ravis RC, et al. Prevalence of left ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population-based study. Lancet 2001; 358: 439-44
4. Packer M, Poole-Wilson A, Armstrong PW. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation 1999; 100: 2312-8
5. Echemann M, Zannad F, Briancon S, et al. Determinants of angiotensin-converting enzyme inhibitor prescription in severe heart failure with left ventricular systolic dysfunction. Am Heart J 2000; 139: 624-31
6. Roe CM, Motheral BR, Teitelbaum F, et al. Angiotensin-converting enzyme inhibitor compliance and dosing among patients with heart failure. Am Heart J 1999; 138: 818-25
7. Croft JB, Giles WH, Pollard RA, et al. Heart failure survival among older adults in the United States: a poor prognosis for an emerging epidemic in the Medicare population. Arch Intern Med 1999; 159: 505-10
8. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study. N Engl J Med 1987; 316: 1429-35
9. Domanski MJ, Garg R, Yusuf S. Prognosis in congestive heart failure. In: Hosenpud JD, Greenberg BH, editors. Congestive heart failure: pathophysiology, diagnosis and comprehensive approach to management. New York: Springer-Verlag, 1994: 622-7
10. Krumholz HM, Parent EM, Tu N, et al. Remission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 1997; 157: 99-104
11. Moser DK. Heart failure management: optimal health care delivery programs. Annu Rev Nurs Res 2000; 18: 91-126
12. McAlister FA, Lawson FME, Teo KK, et al. A systemic review of randomized trials of disease management programs in heart failure. Am J Med 2001; 110: 378-94
13. Rich MW. Heart failure management: optimal health care delivery programs. J Card Fail 1999; 5: 64-75
14. Stewart S, Horowitz JD. Home-based intervention in congestive heart failure: long-term implications on readmission and survival. Circulation 2002; 105: 2861-6
15. Chin MH, Goldman L. Factors contributing to the hospitalization of patients with congestive heart failure. Am J Public Health 1997; 87: 643-8
16. Bennett SJ, Milgrom LB, Chamption V, et al. Beliefs about medication and dietary compliance in people with heart failure: an instrument development study. Heart Lung 1997; 26: 273-9
17. Riegel B, Carlson B, Kopp Z, et al. Effect of a standardized nurse case-management telephone intervention on resource use in patients with chronic heart failure. Arch Intern Med 2002; 162: 705-12
18. Clarke JL, Nash DB. The effectiveness of heart failure disease management: initial findings from a comprehensive program. Dis Manag 2002; 5: 215-23
19. Brass-Mynderse NJ. Disease management for chronic congestive heart failure. J Cardiovasc Nurs 1996; 11: 54-62
20. Paul S. Implementing an outpatient congestive heart failure clinic: the nurse practitioner role. Heart Lung 1997; 26: 486-91
21. Akosah KO, Schaper AM, Havlik P, et al. Improving care for patients with chronic heart failure in the community. Chest 2002; 122: 906-12
22. Whellan DJ, Gaulden L, Gattis WA, et al. The benefit of implementing a heart failure disease management program. Arch Intern Med 2001; 161: 2223-8
23. Ramahi TM, Longo MD, Rohlfs K, et al. Effect of heart failure program on cardiovascular drug utilization and dosage in patients with chronic heart failure. Clin Cardiol 2000; 23: 909-14
24. Fonarow GC, Stevenson LW, Walden JA, et al. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol 1997; 30: 725-32
25. Rich MW, Beckman V, Wittenberg C, et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995; 333: 1190-5
26. Kornowski R, Zeeli D, Averbuch M, et al. Intensive home-care surveillance prevents hospitalization and improves morbidity among elderly patients with severe congestive heart failure. Am Heart J 1995; 129: 762-6
27. Shah NB, Der E, Ruggerio C, et al. Prevention of hospitalizations for heart failure with an interactive home monitoring program. Am Heart J 1998; 135: 373-8
28. Tilney CK, Whiting SB, Horrar JL, et al. Improved clinical and financial outcomes associated with a comprehensive congestive heart failure program. Dis Manag 1998; 1: 175-83
29. West JA, Miller NH, Parker KM, et al. A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization. Am J Cardiol 1997; 79: 58-63
30. Hanumanthu S, Butler J, Chomsky D, et al. Effect of a heart failure program on hospitalization frequency and exercise tolerance. Circulation 1997; 96: 2842-8
31. Krumholz HM, Amatruda J, Smith GL, et al. Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol 2002; 39: 83-9